Wolff A, Oftedal B
Adv Exp Med Biol. 2025; 1471:223-246.
PMID: 40067589
DOI: 10.1007/978-3-031-77921-3_8.
Yang Y, Jiang H, Yang W, Wang H, Wang M, Li X
Front Immunol. 2025; 15():1471115.
PMID: 39840065
PMC: 11746041.
DOI: 10.3389/fimmu.2024.1471115.
Diabetes Care. 2024; 48(Supplement_1):S59-S85.
PMID: 39651988
PMC: 11635044.
DOI: 10.2337/dc25-S004.
Sieber-Ruckstuhl N, Riond B, Fracassi F, Kuemmerle-Fraune C, Meunier S, Hofmann-Lehmann R
J Vet Intern Med. 2024; 39(1):e17232.
PMID: 39531378
PMC: 11627518.
DOI: 10.1111/jvim.17232.
Huang X, Chen Y, Huang X, Tang J
Front Endocrinol (Lausanne). 2024; 15:1403893.
PMID: 38952386
PMC: 11215015.
DOI: 10.3389/fendo.2024.1403893.
Hypoparathyroidism: Musculoskeletal Manifestations Related to Parathormone Deficiency.
Slouma M, Hannech E, Gharsallah I
Curr Rheumatol Rev. 2024; 20(5):488-500.
PMID: 38279727
DOI: 10.2174/0115733971267895231227102539.
Autoimmune Polyendocrine Syndromes in Adult Italian Celiac Disease Patients.
Pallotta D, Granito A, Raiteri A, Boe M, Pratelli A, Giamperoli A
J Clin Med. 2024; 13(2).
PMID: 38256623
PMC: 10815968.
DOI: 10.3390/jcm13020488.
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.
Diabetes Care. 2023; 47(Suppl 1):S52-S76.
PMID: 38078591
PMC: 10725809.
DOI: 10.2337/dc24-S004.
A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
Sapana T, Li W, Tian F, Yan W, Dou B, Hua S
Front Immunol. 2023; 14:1274672.
PMID: 38077387
PMC: 10703372.
DOI: 10.3389/fimmu.2023.1274672.
Correlation analysis between cytokines' profile, autoimmune antibodies and the duration of type 1 diabetes: A case control study in a specialized children's centre in Riyadh.
Al-Dubayee M, Babiker A, Alkewaibeen A, Alkhalifah A, Alanazi T, Nogoud M
Int J Immunopathol Pharmacol. 2023; 37:3946320231209821.
PMID: 37953627
PMC: 10644762.
DOI: 10.1177/03946320231209821.
Autoimmune polyglandular syndrome type 4: experience from a single reference center.
Gatta E, Anelli V, Cimino E, Di Lodovico E, Piovani E, Zammarchi I
Front Endocrinol (Lausanne). 2023; 14:1236878.
PMID: 37937054
PMC: 10627240.
DOI: 10.3389/fendo.2023.1236878.
HbA1c: an independent risk factor for dysthyroid optic neuropathy.
Wang X, Ye H, Chen R, Yang S, Zhang T, Xiao W
Front Endocrinol (Lausanne). 2023; 14:1251209.
PMID: 37881496
PMC: 10597662.
DOI: 10.3389/fendo.2023.1251209.
A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan.
Tseng H, Lin Y, Lin K, Lin C, Li H, Chang C
Eur Thyroid J. 2023; 12(6).
PMID: 37878416
PMC: 10762559.
DOI: 10.1530/ETJ-23-0162.
Effects of hyperthyroidism and diabetes mellitus on spermatogenesis in peri- and post-pubertal mice.
Shi H, Korejo N, Kamboh A, Korejo R, Shi F
Front Endocrinol (Lausanne). 2023; 14:1191571.
PMID: 37654561
PMC: 10465343.
DOI: 10.3389/fendo.2023.1191571.
Approach to the Patient: Diagnosis of Primary Adrenal Insufficiency in Adults.
Oksnes M, Husebye E
J Clin Endocrinol Metab. 2023; 109(1):269-278.
PMID: 37450570
PMC: 10735307.
DOI: 10.1210/clinem/dgad402.
Autoimmune Polyglandular Syndrome Type 3 Complicated with IgG4-related Disease.
Murata Y, Haneda M, Miyakawa N, Nishida S, Kajihara N, Maeda S
Intern Med. 2023; 63(3):425-431.
PMID: 37344441
PMC: 10901709.
DOI: 10.2169/internalmedicine.1270-22.
Research progress on pharmacological effects and mechanisms of cepharanthine and its derivatives.
Shi L, Wang S, Zhang S, Wang J, Chen Y, Li Y
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(11):2843-2860.
PMID: 37338575
DOI: 10.1007/s00210-023-02537-y.
A case report on autoimmune polyglandular syndrome type 2 with pernicious anemia.
Arram N, Riyaz R, Khatroth S, Shrestha A
Clin Case Rep. 2023; 11(6):e7413.
PMID: 37305884
PMC: 10250687.
DOI: 10.1002/ccr3.7413.
The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness.
Fyvie M, Gillespie K
Front Immunol. 2023; 14:1158278.
PMID: 37256143
PMC: 10225507.
DOI: 10.3389/fimmu.2023.1158278.
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)].
Lechleitner M, Kaser S, Hoppichler F, Roden M, Weitgasser R, Ludvik B
Wien Klin Wochenschr. 2023; 135(Suppl 1):98-105.
PMID: 37101030
PMC: 10133075.
DOI: 10.1007/s00508-023-02182-8.
